Global API sourcing simplified
We connect API buyers and suppliers worldwide with speed, trust, and full transparency.

Filters

Filters
Filter
Custom request?
Type
Production region
Qualifications
Show more
Country of origin
Show more

Magnesium Sulfate API Manufacturers & Suppliers

8 verified results
Get full market intelligence report
Get full market intelligence report
Full access. Full negotiation power All Magnesium Sulfate data. Full access. Full negotiation power

Commercial-scale Suppliers

Distributor
Produced in  Germany
|

Employees: 50+

|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: GMP
|
MSDS
|
BSE/TSE
|
ISO 9001
|
coa

All certificates

GMP
MSDS
BSE/TSE
ISO 9001
coa
Producer
Produced in  Japan
|

Employees: 2400+

|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: GMP
|
MSDS
|
BSE/TSE
|
ISO9001
|
CoA

All certificates

GMP
MSDS
BSE/TSE
ISO9001
CoA
Take control of your API sourcing
Submit a Special Inquiry and have Pharmaoffer activate verified suppliers.
Distributor
Produced in  Unknown
|

Employees: 275+

|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: GMP
|
MSDS
|
BSE/TSE
|
ISO9001
|
CoA

All certificates

GMP
MSDS
BSE/TSE
ISO9001
CoA
Producer
Produced in  Netherlands
|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: GMP
|
MSDS
|
BSE/TSE
|
CoA

All certificates

GMP
MSDS
BSE/TSE
CoA
Producer
Produced in  Germany
|

Employees: 1000

|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: GMP
|
USDMF
|
EDMF/ASMF
|
MSDS
|
CoA

All certificates

GMP
USDMF
EDMF/ASMF
MSDS
CoA
Distributor
Produced in  Switzerland
|

Employees: 135+

|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: GMP
|
MSDS
|
CoA

All certificates

GMP
MSDS
CoA
Get full market intelligence report
Get full market intelligence report
€399,-
All Magnesium Sulfate data. Full access. Full negotiation power
Producer
Produced in  Japan
|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: USDMF
|
JDMF
|
CoA

All certificates

USDMF
JDMF
CoA
Producer
Produced in  United States
|

Employees: 500

|
Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested!
Certifications: USDMF
|
CoA

All certificates

USDMF
CoA
When insight is your advantage
Full data, full access, full negotiation power
Total market transparency Total market transparency
|
Supplier trade data access Supplier trade data access
|
Buyer / supplier flow comparison Buyer / supplier flow comparison
Trusted by 30,000+ registered pharma professionals:
Reach multinationals, SMEs, compounding pharmacies & more!
Procaps
Pfizer
Reckitt
Sanofi
Blau
Abbvie

Magnesium sulfate | CAS No: 7487-88-9 | GMP-certified suppliers

A medication that provides rapid control of convulsions in severe pre‑eclampsia and eclampsia, supports acute nephritis care, corrects magnesium deficiency, and manages uterine tetany.

Therapeutic categories

Agents causing hyperkalemiaAgents that produce neuromuscular block (indirect)Alimentary Tract and MetabolismAnalgesicsAnestheticsAntiarrhythmic agents
Generic name
Magnesium sulfate
Molecule type
small molecule
CAS number
7487-88-9
DrugBank ID
DB00653
Approval status
Approved drug, Investigational drug, Vet_approved drug
ATC code
A06AD04

Primary indications

  • Used for immediate control of life-threatening convulsions in the treatment of severe toxemias (pre-eclampsia and eclampsia) of pregnancy and in the treatment of acute nephritis in children
  • Also indicated for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those of hypocalcemia
  • Also used in uterine tetany as a myometriat relaxant

Product Snapshot

  • Magnesium sulfate is supplied in multiple formulation types, primarily as parenteral injectable solutions and powders for reconstitution, with additional oral and topical forms
  • It is used for control of severe pregnancy-related convulsions, correction of acute magnesium deficiency, and management of uterine tetany and related neuromuscular hyperexcitability states
  • It is approved for use in the US and Canada, with statuses including approved, investigational, and veterinary‑approved

Clinical Overview

Magnesium sulfate (CAS 7487-88-9) is an inorganic magnesium salt widely used in acute obstetric and critical care settings. Its primary clinical indication is the rapid control of convulsions in severe pre‑eclampsia and eclampsia. It is also employed in pediatric acute nephritis when symptomatic hypomagnesemia contributes to neuromuscular irritability, and as replacement therapy in acute magnesium deficiency. Additional uses include management of uterine tetany as a myometrial relaxant and selected arrhythmias such as torsades de pointes, particularly when associated with electrolyte disturbances or drug toxicity.

Pharmacologically, magnesium sulfate acts as an anticonvulsant, cathartic, and electrolyte replenisher. It dampens excitability in myometrial muscle cells by directly inhibiting action potentials, uncoupling excitation–contraction processes and reducing contraction frequency and intensity. It contributes to stabilization of cardiac electrophysiology in settings of polymorphic ventricular tachycardia where magnesium-dependent ion flux is disrupted.

The mechanism of action reflects magnesium’s role as a major intracellular cation required for numerous enzymatic reactions. The sulfate salt reduces acetylcholine release at the neuromuscular junction and diminishes striated muscle contractions. Inhibition of calcium influx through voltage-dependent, dihydropyridine-sensitive channels underlies its vasodilatory and smooth muscle relaxant effects, which are clinically relevant during obstetric emergencies.

Absorption and distribution characteristics vary by route; parenteral administration achieves rapid systemic exposure. Magnesium is primarily eliminated renally, and accumulation can occur in renal impairment. Safety considerations include the risk of respiratory depression, hypotension, loss of deep tendon reflexes, and conduction abnormalities at elevated serum magnesium concentrations. Clinical use typically incorporates serum level monitoring and availability of calcium salts for antagonism in cases of toxicity.

Magnesium sulfate is supplied globally in injectable solutions and oral formulations such as osmotic laxatives. When procuring the API, sourcing teams should confirm compliance with pharmacopoeial monographs, control of inorganic impurities, and suitability for parenteral-grade manufacturing where required.

Identification & chemistry

Generic name Magnesium sulfate
Molecule type Small molecule
CAS 7487-88-9
UNII ML30MJ2U7I
DrugBank ID DB00653

Pharmacology

SummaryMagnesium sulfate acts primarily by modulating neurochemical transmission and muscular excitability through inhibition of voltage‑dependent L‑type calcium channels and reduced acetylcholine release at the neuromuscular junction. These actions decrease striated and smooth muscle contractility, including in myometrial and vascular tissues. Its pharmacodynamic profile supports use in conditions characterized by convulsions, abnormal uterine contractility, certain arrhythmias, and acute magnesium deficiency.
Mechanism of actionMagnesium is the second most plentiful cation of the intracellular fluids. It is essential for the activity of many enzyme systems and plays an important role with regard to neurochemical transmission and muscular excitability. Magnesium sulfate reduces striated muscle contractions and blocks peripheral neuromuscular transmission by reducing acetylcholine release at the myoneural junction. Additionally, Magnesium inhibits Ca<sup>2+</sup> influx through dihydropyridine-sensitive, voltage-dependent channels. This accounts for much of its relaxant action on vascular smooth muscle.
PharmacodynamicsMagnesium sulfate is a small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. Magnesium sulfate is gaining popularity as an initial treatment in the management of various dysrhythmias, particularly torsades de pointes, and dyrhythmias secondary to TCA overdose or digitalis toxicity.
Targets
TargetOrganismActions
Voltage-dependent L-type calcium channelHumansinhibitor, blocker

ADME / PK

Half-life43.2 hours (for newborns)
Protein binding25-30%
MetabolismNone
Route of eliminationMagnesium is excreted solely by the kidney at a rate proportional to the serum concentration and glomerular filtration.

Formulation & handling

  • Highly water‑soluble inorganic salt suitable for oral solutions, suspensions, and effervescent tablets, with minimal formulation challenges related to permeability or food effects.
  • Widely used in parenteral solutions where concentration, osmolarity, and pH control are critical to avoid irritation and ensure compatibility with aqueous systems.
  • Stable as a solid and in aqueous solution; hygroscopicity should be managed in bulk handling to prevent caking and maintain flow properties.

Regulatory status

LifecycleMost U.S. patents covering the API extend to 2037, with one earlier patent having expired in 2023, indicating that the product remains largely within a protected period in its primary markets. Given commercialization in the United States and Canada, the API is still in a mid‑to‑late patent‑protected phase with limited near‑term generic entry expected.
MarketsUS, Canada
Supply Chain
Supply chain summaryMagnesium sulfate is supplied by a small group of established manufacturers, with a wider set of packagers supporting distribution. Branded and non‑branded products are present primarily in the US and Canada, reflecting broad clinical and consumer use. Core molecule patents have largely expired, while later‑dated patents appear to relate to specific formulations or uses, indicating that generic competition is already well established for the underlying API.

Safety

ToxicityLD<sub>50</sub> = 1200 mg/kg (rat, subcutaneous). May be harmful if swallowed. May act as an irritant. Adverse reactions include hypotension, ECG changes, diarrhea, urinary retention, CNS depression and respiratory depression.
High Level Warnings:
  • Subcutaneous LD50 in rats is 1200 mg/kg
  • Oral exposure may be harmful and the compound can exhibit irritant properties
  • Reported adverse effects include hypotension, ECG alterations, gastrointestinal disturbances, urinary retention, and CNS and respiratory depression

Magnesium Sulfate is a type of Magnesium Salts


Magnesium salts are a crucial subcategory of active pharmaceutical ingredients (APIs) widely used in the pharmaceutical industry. These salts are compounds formed by combining magnesium with other chemical elements or groups. Magnesium salts are highly valued for their therapeutic properties and play a significant role in various medical applications.

One of the most well-known magnesium salts is magnesium oxide, which is commonly used as a supplement to treat magnesium deficiency in the body. This salt is known for its high bioavailability, making it an effective option for oral administration.

Another important magnesium salt is magnesium sulfate, which finds extensive use in both pharmaceutical and medical settings. It is often utilized in the treatment of conditions such as eclampsia, pre-eclampsia, and magnesium deficiency in pregnant women. Magnesium sulfate can be administered intravenously or orally, depending on the specific medical requirements.

Furthermore, magnesium citrate, a salt formed by combining magnesium with citric acid, is renowned for its laxative properties. It is frequently employed in the formulation of bowel preparations to facilitate bowel movements before medical procedures or surgeries.

The versatility of magnesium salts extends beyond medical applications. They are also utilized in the manufacturing of antacids, laxatives, and various over-the-counter products.

In conclusion, magnesium salts form a significant subcategory of pharmaceutical APIs, offering a wide range of therapeutic benefits. These salts, including magnesium oxide, magnesium sulfate, and magnesium citrate, play vital roles in treating magnesium deficiencies, supporting pregnancy-related conditions, and aiding bowel movements. Their extensive usage and efficacy make them indispensable components in the pharmaceutical industry.


Magnesium Sulfate (Magnesium Salts), classified under Therapeutic Nutrients/Minerals/Electrolyte


Therapeutic Nutrients/Minerals/Electrolytes: A Comprehensive Technical DescriptionTherapeutic nutrients, minerals, and electrolytes are a vital category of pharmaceutical active pharmaceutical ingredients (APIs) used to support and enhance overall health and well-being. These compounds play a crucial role in maintaining the body's physiological balance, aiding in various metabolic processes, and addressing specific deficiencies.

Therapeutic nutrients encompass a broad range of substances, including vitamins, minerals, and electrolytes. Vitamins are organic compounds required in small quantities for proper bodily functions and are essential for growth, development, and disease prevention. Minerals, on the other hand, are inorganic substances that support numerous physiological processes, such as bone formation, nerve function, and energy production.

Electrolytes are minerals that carry an electric charge when dissolved in bodily fluids, including sodium, potassium, calcium, magnesium, and chloride. They play a crucial role in maintaining proper hydration, nerve impulses, muscle contractions, and pH balance.

Pharmaceutical APIs in the Therapeutic Nutrients/Minerals/Electrolyte category are designed to address specific deficiencies or imbalances in the body. These APIs are often used in the formulation of dietary supplements, nutritional products, and therapeutic treatments. They are manufactured under stringent quality control guidelines to ensure purity, potency, and bioavailability.

Therapeutic nutrients/minerals/electrolytes APIs are available in various forms, including tablets, capsules, powders, and liquid formulations. They are formulated to meet specific dosage requirements and can be combined with other ingredients for targeted health benefits.

Overall, therapeutic nutrients, minerals, and electrolytes APIs are essential components in maintaining optimal health. Their use helps address deficiencies, support bodily functions, and promote overall well-being. Pharmaceutical companies and healthcare professionals rely on these high-quality APIs to develop effective and safe products that contribute to a healthier population.



Magnesium Sulfate API manufacturers & distributors

Compare qualified Magnesium Sulfate API suppliers worldwide. We currently have 8 companies offering Magnesium Sulfate API, with manufacturing taking place in 6 different countries. Use the table below to review supplier type, countries of origin, certifications, product portfolio and GMP audit availability.

SupplierTypeCountryProduct originCertificationsPortfolio
Producer
Netherlands Netherlands BSE/TSE, CoA, GMP, MSDS67 products
Distributor
Germany Unknown BSE/TSE, CoA, GMP, ISO9001, MSDS211 products
Producer
Germany Germany CoA, EDMF/ASMF, GMP, MSDS, USDMF49 products
Distributor
Netherlands Germany BSE/TSE, CoA, GMP, ISO9001, MSDS170 products
Producer
Japan Japan BSE/TSE, CoA, GMP, ISO9001, MSDS55 products
Distributor
Switzerland Switzerland CoA, GMP, MSDS174 products
Producer
United States United States CoA, USDMF14 products
Producer
Japan Japan CoA, JDMF, USDMF10 products

When sending a request, specify which Magnesium Sulfate API quality you need: for example EP (Ph. Eur.), USP, JP, BP, or another pharmacopoeial standard, as well as the required grade (base, salt, micronised, specific purity, etc.).

Use the list above to find high-quality Magnesium Sulfate API suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our help page to learn more about sourcing APIs via Pharmaoffer.

Frequently asked questions about Magnesium Sulfate API


Sourcing

What matters most when sourcing GMP-grade Magnesium Sulfate?
Key considerations include confirming GMP compliance and regulatory suitability for use in the US and Canada. Because supply comes from a small group of established manufacturers with additional packagers, assessing manufacturer reliability and supply continuity is important. It is also useful to understand whether the product is branded or non‑branded, as both circulate widely in these markets. The mature patent landscape indicates that sourcing generally involves established generic API producers.
Which documents are typically required when sourcing Magnesium Sulfate API?
Request the core API documentation set: CoA (8 companies), MSDS (6 companies), GMP (6 companies), BSE/TSE (4 companies), ISO9001 (3 companies). Confirm versions and validity dates match the destination market to avoid delays in qualification.
Which manufacturers are known to produce Magnesium Sulfate API?
Known or reported manufacturers for Magnesium Sulfate: Duchefa Farma B.V., Caesar & Loretz GmbH (CAELO), Fujifilm Wako Pure Chemical Corporation, Hänseler AG, Dr. Paul Lohmann GmbH & Co. KGaA, Acta minerals. Evaluate their GMP history, scale, and regional coverage before requesting dossiers or allocating demand.
How can I request quotes for Magnesium Sulfate API from GMP suppliers?
Submit quote requests through the supplier listings with your specs and required documents (specifications, target volume, delivery timeline, and destination). Providing consistent details upfront speeds comparable offers and clarifies technical feasibility.
Is a GMP audit report available for Magnesium Sulfate manufacturers?
Audit reports may be requested for Magnesium Sulfate: 0 GMP audit reports available. Confirm the scope and recency of any audit before relying on it for qualification decisions.
How many suppliers offer Magnesium Sulfate API on Pharmaoffer?
Reported supplier count for Magnesium Sulfate: 8 verified suppliers. Filter listings by certifications, regions, and delivery options to match your qualification plan.
Which countries are known to manufacture Magnesium Sulfate API?
Production countries reported for Magnesium Sulfate: Germany (2 producers), Japan (2 producers), Switzerland (1 producer). Knowing the manufacturing geography helps anticipate logistics lead times and import compliance needs.
Which certifications do suppliers of Magnesium Sulfate usually hold?
Common certifications for Magnesium Sulfate suppliers: CoA (8 companies), MSDS (6 companies), GMP (6 companies), BSE/TSE (4 companies), ISO9001 (3 companies). Always verify issuing authorities and expiry dates when reviewing audit packages.

Technical

What is Magnesium Sulfate (CAS 7487-88-9) used for?
Magnesium Sulfate is used to control convulsions in severe pre‑eclampsia and eclampsia, and to treat symptomatic hypomagnesemia or acute magnesium deficiency. It also functions as a myometrial and smooth‑muscle relaxant for conditions such as uterine tetany, and stabilizes cardiac electrophysiology in arrhythmias like torsades de pointes associated with electrolyte imbalance. Additional uses include pediatric acute nephritis when neuromuscular irritability is linked to low magnesium levels.
Which therapeutic class does Magnesium Sulfate fall into?
Magnesium Sulfate belongs to the following therapeutic categories: Agents causing hyperkalemia, Agents that produce neuromuscular block (indirect), Alimentary Tract and Metabolism, Analgesics, Anesthetics. This positioning helps teams compare alternative APIs, anticipate pharmacology expectations, and align early research priorities.
What conditions is Magnesium Sulfate mainly prescribed for?
The primary indications for Magnesium Sulfate: Used for immediate control of life-threatening convulsions in the treatment of severe toxemias (pre-eclampsia and eclampsia) of pregnancy and in the treatment of acute nephritis in children, Also indicated for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those of hypocalcemia, Also used in uterine tetany as a myometriat relaxant. These use cases frame the target patient populations and help prioritize formulation and safety evaluations.
How does Magnesium Sulfate work?
Magnesium is the second most plentiful cation of the intracellular fluids. It is essential for the activity of many enzyme systems and plays an important role with regard to neurochemical transmission and muscular excitability. Magnesium Sulfate reduces striated muscle contractions and blocks peripheral neuromuscular transmission by reducing acetylcholine release at the myoneural junction. Additionally, Magnesium inhibits Ca2+ influx through dihydropyridine-sensitive, voltage-dependent channels. This accounts for much of its relaxant action on vascular smooth muscle.
What should someone know about the safety or toxicity profile of Magnesium Sulfate?
Magnesium Sulfate can cause dose‑related hypotension, ECG changes, gastrointestinal upset, urinary retention, and central nervous system or respiratory depression. Elevated serum magnesium levels may lead to loss of deep tendon reflexes and conduction abnormalities, with increased risk in renal impairment due to reduced elimination. Oral exposure may be harmful and the compound can be irritant; the subcutaneous LD50 in rats is 1200 mg/kg. Clinical use typically includes serum magnesium monitoring and readiness to administer calcium salts in cases of toxicity.
What are important formulation and handling considerations for Magnesium Sulfate as an API?
Important considerations include its high water solubility, which supports use in oral and parenteral aqueous formulations but requires attention to solution concentration, osmolarity, and pH to avoid irritation and ensure compatibility. Its hygroscopic nature necessitates controlled humidity during storage and handling to prevent caking and maintain flow. The solid and solution forms are generally stable, and no specific permeability or food‑effect issues influence formulation design.
Is Magnesium Sulfate a small molecule?
Magnesium Sulfate is classified as a small molecule. That classification shapes process design, impurity profiling, and analytical control strategies.
Are there special stability concerns for oral Magnesium Sulfate?
Oral Magnesium Sulfate is generally stable as both a solid and in aqueous solution. Its main stability concern is hygroscopicity, which can lead to caking and impaired flow if not protected from moisture. Standard moisture‑control measures are typically sufficient to maintain product integrity.

Regulatory

Where is Magnesium Sulfate approved or in use globally?
Magnesium Sulfate is reported as approved in the following major regions: US, Canada. Understanding geographic coverage informs regulatory filings, supply planning, and risk assessments before escalating procurement.
What’s the regulatory and patent landscape for Magnesium Sulfate right now?
Magnesium Sulfate is an established, long‑standing API regulated for medical use in both the United States and Canada under their standard frameworks for approved drug substances. As a mature inorganic compound long in clinical use, it is generally not subject to active patent protection.

Pharmaoffer

How does Pharmaoffer’s Smart Sourcing Service help with Magnesium Sulfate procurement?
Pharmaoffer's Smart Sourcing Service coordinates compliant suppliers, documentation, and competitive quotes for Magnesium Sulfate. It centralizes outreach, follow-ups, and document validation to shorten procurement timelines.
Is Magnesium Sulfate included in the PRO Data Insights coverage?
PRO Data Insights coverage for Magnesium Sulfate: 128 verified transactions across 47 suppliers and 46 buyers worldwide. Use the dataset to benchmark suppliers and monitor regulatory activity where available.
Where can I access the API market report for Magnesium Sulfate?
Market report availability for Magnesium Sulfate: Report Available. The report highlights demand trends, pricing drivers, and supplier landscape insights for procurement planning.